Autoimmune disease prevention
Do omega-3s prevent autoimmune disease?
VITAL’s randomized treatment period did not show a statistically significant omega-3 reduction in confirmed autoimmune disease. Extended follow-up reported a signal that needs careful interpretation.
Updated September 24, 2026 · Editorial attribution: PV Griscom, M.Sc. · Independent clinical review pending
The question behind the headline
Older adults without selection for a specific autoimmune disease; 1 g/day marine omega-3 in VITAL.
What the finding does—and doesn’t—tell us
Vitamin D results cannot be attributed to omega-3. Combined autoimmune endpoints do not prove prevention of each individual disease. Post-trial follow-up differs from continued randomized treatment.
Read the underlying research.
- Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. · 2022 ↗
- Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial. · 2024 ↗
Selected sources, not an exhaustive reference list. Rating draws on published results and review summaries; no independent full systematic review has been conducted. Source publication dates may precede this page’s update date.
Three questions to take forward
- Was the study population similar to the person or situation I have in mind?
- Did it measure an outcome people feel or experience, or only a laboratory marker?
- How do formulation, usual care, absolute benefit and adverse effects change the interpretation?
Study doses describe experiments; they are not personal dosing advice. Explore safety and limitations ↗